Appeals court reverses $1.2bn judgment against Gilead in BMS CAR-T caseGilead Sciences’ Kite Pharma has won a key victory on appeal in its long-running dispute with Bristol Myers Share XAppeals court reverses $1.2bn judgment against Gilead in BMS CAR-T casehttps://pharmaphorum.com/news/appeals-court-reverses-1-2bn-judgment-against-gilead-in-bms-car-t-case/
Celgene seals Juno acquisition for $9bnCelgene has today confirmed that it will acquire Juno Therapeutics for $9 billion, and says the move will Share XCelgene seals Juno acquisition for $9bnhttps://pharmaphorum.com/news/celgene-agrees-buy-juno-9bn/
